Thus, given an absence of cytokines in our proteomic study, the downregulation of VCAM-1 in ALS MCEVs is consistent with the literature concerning VCAM-1 levels in an ALS tissue-specific setting. The gene discussed is VCAM1; the disease is amyotrophic lateral sclerosis.